|
A.V. Novik (1, 2), A.B. Danilova (1), T.L. Nekhaeva (1), N.V. Emelyanova (1), A.I. Semenova (1), D.Kh. Latipova (1), G.M. Teletaeva (1), S.A. Protsenko (1), I.A. Baldueva (1)
Assessment of the dynamics of immunological parameters at the beginning of therapy as prognostic and predictive factors in patients with melanoma
|
№7 / 2021
|
|
A.P. Polyakov, A.V. Mordovsky
Current therapy strategy for metastatic BRAF-positive skin melanoma
|
№11 / 2020
|
|
Yu.Yu. Sergeev (1, 3), V.V. Mordovtseva (2), V.Yu. Sergeev (3)
SKIN MELANOMA IN PRACTICE OF DERMATOLOGIST
|
№17 / 2017
|
|
G.A. Khakimov (1), Sh. Sh. Kadyrov (1), G.G. Khakimova (2), U.Sh. Niezaliyev (3), Kh.I. Dzhumaniezov (1), Sh.V. Ziyaev (1)
CASHUISTIC CASE OF MELANOMA
|
№8 / 2017
|
|
D.R. Naskhletashvili, V.A. Gorbunova, A.Kh. Bekyashev, L.V. Demidov, G.Yu. Kharkevich, I.V. Samoylenko, K.A. Baryshnikov, K.V. Orlova, I.A. Utyashev, N.N. Petenko, I.G. Markina, E.A. Moskvina
COMBINED TARGETED THERAPY WITH DABRAPHENIB+TRAMETINIB IN TREATMENT OF MELANOMA PATIENTS WITH V600 BRAF MUTATIONS AND BRAIN METASTASES
|
№8 / 2017
|
|
Yu.Yu. Sergeev (1, 2), O.Yu. Olisova (1), V.Yu. Sergeev (2)
POTENTIALS FOR THE EARLY DIAGNOSIS AND PREVENTION OF SKIN CANCER
|
№s2-16 / 2016
|
|
Z.G. Kadagidze, E.G. Slavina, A.I. Chertkova, M.E Abramov
INFLUENCE OF REFNOT ON IMMUNITY IN CANCER PATIENTS
|
№8 / 2015
|
|
N.V. Dobrova
NEW POTENTIALS FOR THE USE OF TARGETED THERAPY IN THE TREATMENT OF SOME SOLID TUMORS (BASED ON ESMO 2014)
|
№17 / 2014
|
|
G.Yu. Kharkevich, K.V. Orlova, L.V. Demidov
NEW DRUGS RESTORING THE IMMUNE TUMOR CONTROL IN THE TREATMENT OF PATIENTS WITH METASTATIC MELANOMA
|
№17 / 2014
|
Русский
